Anteris Technologies Global Corp. Common Stock
Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also develops ADAPT anti-calci… Read more
Anteris Technologies Global Corp. Common Stock (AVR) - Net Assets
Latest net assets as of September 2025: $3.36 Million USD
Based on the latest financial reports, Anteris Technologies Global Corp. Common Stock (AVR) has net assets worth $3.36 Million USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($19.07 Million) and total liabilities ($15.71 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $3.36 Million |
| % of Total Assets | 17.61% |
| Annual Growth Rate | 141.07% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 177.79 |
Anteris Technologies Global Corp. Common Stock - Net Assets Trend (2020–2024)
This chart illustrates how Anteris Technologies Global Corp. Common Stock's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Anteris Technologies Global Corp. Common Stock (2020–2024)
The table below shows the annual net assets of Anteris Technologies Global Corp. Common Stock from 2020 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $62.68 Million | +231.68% |
| 2023-12-31 | $18.90 Million | +109.21% |
| 2022-12-31 | $9.03 Million | -14.17% |
| 2021-12-31 | $10.52 Million | +467.08% |
| 2020-12-31 | $1.86 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Anteris Technologies Global Corp. Common Stock's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 17247699000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $4.00K | 0.01% |
| Other Comprehensive Income | $-10.89 Million | -17.35% |
| Other Components | $350.04 Million | 557.73% |
| Total Equity | $62.76 Million | 100.00% |
Anteris Technologies Global Corp. Common Stock Competitors by Market Cap
The table below lists competitors of Anteris Technologies Global Corp. Common Stock ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Sonda S.A
SN:SONDA
|
$156.17 Million |
|
Hangzhou Hopechart Iot Technology
SHG:688288
|
$156.17 Million |
|
Harvard Ave Acquisition Corporation Class A Ordinary Share
NASDAQ:HAVA
|
$156.19 Million |
|
Doosan Skoda Power as
PR:DSPW
|
$156.20 Million |
|
Ameritrust Corp
PINK:ATCC
|
$156.13 Million |
|
BANK OG TIANJIN H YC1
F:B95
|
$156.12 Million |
|
TEN SQUARE GAMES SA
WAR:TEN
|
$156.08 Million |
|
Vysarn Ltd
AU:VYS
|
$156.06 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Anteris Technologies Global Corp. Common Stock's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 19,300,908 to 62,761,000, a change of 43,460,092 (225.2%).
- Net loss of 76,291,000 reduced equity.
- Other comprehensive income decreased equity by 1,335,624.
- Other factors increased equity by 121,086,716.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-76.29 Million | -121.56% |
| Other Comprehensive Income | $-1.34 Million | -2.13% |
| Other Changes | $121.09 Million | +192.93% |
| Total Change | $- | 225.17% |
Book Value vs Market Value Analysis
This analysis compares Anteris Technologies Global Corp. Common Stock's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.93x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 115.60x to 1.93x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2020-12-31 | $0.05 | $5.97 | x |
| 2021-12-31 | $0.29 | $5.97 | x |
| 2022-12-31 | $0.25 | $5.97 | x |
| 2023-12-31 | $0.54 | $5.97 | x |
| 2024-12-31 | $3.10 | $5.97 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Anteris Technologies Global Corp. Common Stock utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -121.56%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -2822.46%
- • Asset Turnover: 0.03x
- • Equity Multiplier: 1.29x
- Recent ROE (-121.56%) is above the historical average (-299.21%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2020 | -634.53% | -215.78% | 0.56x | 5.26x | $-11.96 Million |
| 2021 | -163.15% | -294.50% | 0.27x | 2.04x | $-18.22 Million |
| 2022 | -338.35% | -954.91% | 0.20x | 1.77x | $-31.47 Million |
| 2023 | -238.44% | -1682.81% | 0.09x | 1.58x | $-47.95 Million |
| 2024 | -121.56% | -2822.46% | 0.03x | 1.29x | $-82.57 Million |
Industry Comparison
This section compares Anteris Technologies Global Corp. Common Stock's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $2,980,692,467
- Average return on equity (ROE) among peers: 1.51%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Anteris Technologies Global Corp. Common Stock (AVR) | $3.36 Million | -634.53% | 4.68x | $156.14 Million |
| ANGELALIGN TECHNOLOGY INC (AGLFF) | $480.24 Million | 2.52% | 0.41x | $405.57 Million |
| Akoya Biosciences Inc (AKYA) | $-30.16 Million | 0.00% | 0.00x | $16.24 Million |
| Alcon AG (ALC) | $19.68 Billion | 1.70% | 0.48x | $37.82 Billion |
| Align Technology Inc (ALGN) | $3.85 Billion | 10.94% | 0.61x | $11.75 Billion |
| AngioDynamics Inc (ANGO) | $355.71 Million | 3.06% | 0.15x | $354.40 Million |
| Ansell Limited (ANSLF) | $386.33 Million | -0.45% | 0.87x | $2.58 Billion |
| AptarGroup Inc (ATR) | $2.07 Billion | 11.57% | 1.03x | $8.27 Billion |
| AtriCure Inc (ATRC) | $72.60 Million | -15.79% | 0.54x | $1.42 Billion |
| Avinger Inc (AVGR) | $-35.69 Million | 0.00% | 0.00x | $1.26 Million |